BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32494773)

  • 1. Cohort study to evaluate efficacy, safety and acceptability of a two-rod contraceptive implant during third, fourth and fifth year of product use in China.
    Che Y; Taylor D; Luo D; Maldonado LY; Wang M; Wevill S; Vahdat H; Han X; Halpern V; Dorflinger L; Steiner MJ
    Contracept X; 2019; 1():100008. PubMed ID: 32494773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial to evaluate contraceptive efficacy, safety and acceptability of a two-rod contraceptive implant over 4 years in the Dominican Republic.
    Steiner MJ; Brache V; Taylor D; Callahan R; Halpern V; Jorge A; Wevill S; Sergison J; Venkatasubramanian L; Dorflinger L
    Contracept X; 2019; 1():100006. PubMed ID: 32494772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.
    Ali M; Akin A; Bahamondes L; Brache V; Habib N; Landoulsi S; Hubacher D;
    Hum Reprod; 2016 Nov; 31(11):2491-2498. PubMed ID: 27671673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contraception with two levonorgestrel rod implants. A 5-year study in the United States and Dominican Republic.
    Sivin I; Alvarez F; Mishell DR; Darney P; Wan L; Brache V; Lacarra M; Klaisle C; Stern J
    Contraception; 1998 Nov; 58(5):275-82. PubMed ID: 9883382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Norplant implants among Thai women in Bangkok.
    Chompootaweep S; Kochagarn E; Sirisumpan S; Tang-usaha J; Theppitaksak B; Dusitsin N
    Contraception; 1996 Jan; 53(1):33-6. PubMed ID: 8631187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levonorgestrel release rates measured through analysis of two-rod contraceptive explants.
    Fuchs R; Taylor D; Jenkins DW; Brache V; Luo D; Dorflinger LJ; Steiner MJ
    Contracept X; 2020; 2():100039. PubMed ID: 32995746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness, safety and acceptability of Sino-implant (II) during the first year of use: results from Kenya and Pakistan.
    Lendvay A; Otieno-Masaba R; Azmat SK; Wheeless A; Hameed W; Shaikh BT; Kuria S; Steiner MJ; Chen M; Feldblum PJ
    Contraception; 2014 Mar; 89(3):197-203. PubMed ID: 24439674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
    Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S;
    Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pearl Index study with levonorgestrel-releasing intravaginal rings: using pharmacokinetic results to investigate treatment compliance as a potential contributor for contraceptive failure.
    Nave R; Höchel J; Mellinger U; Kohnke A; Elliesen J; Schmitz H
    Hum Reprod; 2020 Nov; 35(11):2515-2523. PubMed ID: 32914172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo release of levonorgestrel from Sino-implant (II) — an innovative comparison of explant data.
    Callahan RL; Taylor D; Jenkins DW; Owen DH; Cheng L; Cancel AM; Dorflinger LJ; Steiner MJ
    Contraception; 2015 Oct; 92(4):350-5. PubMed ID: 26142619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
    McNicholas C; Swor E; Wan L; Peipert JF
    Am J Obstet Gynecol; 2017 Jun; 216(6):586.e1-586.e6. PubMed ID: 28147241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sino-implant (II)--a levonorgestrel-releasing two-rod implant: systematic review of the randomized controlled trials.
    Steiner MJ; Lopez LM; Grimes DA; Cheng L; Shelton J; Trussell J; Farley TM; Dorflinger L
    Contraception; 2010 Mar; 81(3):197-201. PubMed ID: 20159174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subdermal contraceptive implants.
    Peralta O; Diaz S; Croxatto H
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):223-6. PubMed ID: 7626459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
    Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
    Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First week drug concentrations in women with levonorgestrel rod or Norplant capsule implants.
    Sivin I; Lähteenmäki P; Mishell DR; Alvarez F; Diaz S; Ranta S; Grozinger C; Lacarra M; Brache V; Pavez M; Nash H; Stern J
    Contraception; 1997 Nov; 56(5):317-21. PubMed ID: 9437561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal intrauterine devices.
    Rybo G; Andersson K; Odlind V
    Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
    Sivin I; Campodonico I; Kiriwat O; Holma P; Diaz S; Wan L; Biswas A; Viegas O; el din Abdalla K; Anant MP; Pavez M; Stern J
    Hum Reprod; 1998 Dec; 13(12):3371-8. PubMed ID: 9886517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
    Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium
    Lancet; 2019 Jul; 394(10195):303-313. PubMed ID: 31204114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter randomized clinical trial of etonogestrel and levonorgestrel contraceptive implants with nonrandomized copper intrauterine device controls: effect on weight variations up to 3 years after placement.
    Bahamondes L; Brache V; Ali M; Habib N;
    Contraception; 2018 Sep; 98(3):181-187. PubMed ID: 29777663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A five-year clinical evaluation of Norplant contraceptive subdermal implants in Bangladeshi acceptors.
    Akhter H; Dunson TR; Amatya RN; Begum K; Chowdhury T; Dighe N; Krueger SL; Rahman S
    Contraception; 1993 Jun; 47(6):569-82. PubMed ID: 8334891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.